These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Yu AW; Zhou XJ; Zhou FQ; Nawab ZM; Gandhi VC; Ing TS; Vaziri ND Int J Artif Organs; 1992 Nov; 15(11):661-5. PubMed ID: 1490758 [TBL] [Abstract][Full Text] [Related]
7. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose. Martinson E; Wieslander A; Kjellstrand P; Boberg U ASAIO J; 1992; 38(3):M370-2. PubMed ID: 1457884 [TBL] [Abstract][Full Text] [Related]
8. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients. Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836 [TBL] [Abstract][Full Text] [Related]
9. Effect of an pyruvate-based peritoneal dialysis solution on the pH of a residual peritoneal dialysis fluid. Ing TS; Yang ML; Yang VL; Wong FK; Cheng YL; Guddeti SR; Yu AW Artif Organs; 1996 Mar; 20(3):264-6. PubMed ID: 8694698 [TBL] [Abstract][Full Text] [Related]
10. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]. Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F; BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574 [TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis. Higuchi C; Nishimura H; Sanaka T Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191 [TBL] [Abstract][Full Text] [Related]
12. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of intermittent peritoneal dialysis. III]. Grzegorzewska A Przegl Lek; 1988; 45(10):721-8. PubMed ID: 3244837 [No Abstract] [Full Text] [Related]
14. Lactate-containing peritoneal dialysis solutions. Ing TS; Zhou XJ; Yu AW; Zhou FQ; Vaziri ND Int J Artif Organs; 1993 Oct; 16(10):688-93. PubMed ID: 8125613 [No Abstract] [Full Text] [Related]
15. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis]. Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197 [TBL] [Abstract][Full Text] [Related]
17. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis]. Haag-Weber M Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339 [TBL] [Abstract][Full Text] [Related]
19. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure. Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell transplantation may provide a new therapy for ultrafiltration failure in chronic peritoneal dialysis. Bastug F; Gündüz Z; Tülpar S; Torun YA; Akgün H; Dörterler E; Düsünsel R; Poyrazoglu H; Bastug O; Dursun I; Yel S Nephrol Dial Transplant; 2013 Oct; 28(10):2493-501. PubMed ID: 23880789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]